HybridActive

preparation therapy Courses

Courses tagged with preparation therapy focus on ketamine-assisted psychotherapy and psychedelic-assisted psychotherapy practice. The current catalog includes two offerings from one provider, with formats that combine didactic learning, consultation, supervision, and shadowing.

Schedule

Next cohort: Dec 1, 2026

8 weeks

Enrollment

Price on request

Decision Summary

Best fit
Practitioners interested in ketamine-assisted psychotherapy and psychedelic-assisted psychotherapy practice.
Format
Hybrid
Time commitment
8 weeks
Credential signal
Not listed

Upcoming Cohort

Start date: December 1, 2026

Course Overview

This course topic covers preparation therapy as used in the current PsychedelicsCourses catalog. The listed courses emphasize ketamine-assisted psychotherapy and psychedelic-assisted psychotherapy practice, with an applied focus on preparation, consultation, and clinical skills. The current catalog includes two courses from Mind Medicine Australia / Institute for Integrative Therapies. One is an 8-week guided externship for practitioners who have completed prior KAP training; it includes case consultation, individual supervision, didactic and consultation groups, and shadowing of medical and therapy staff. The other is an 8-week apprenticeship program designed to build foundational skills in ketamine-assisted psychotherapy and psychedelic-assisted psychotherapy practice. It includes didactic learning, small group breakout sessions, consultation, and shadowing. These courses are aimed at practitioners and are listed at professional or beginner level depending on the program.

Who is this for?

Practitioners interested in ketamine-assisted psychotherapy and psychedelic-assisted psychotherapy practice.

Prerequisites

One listed course is for practitioners who have completed prior KAP training; the other does not list prerequisites in the provided text.

About the Provider

Australian registered charity founded in 2019 that successfully campaigned for the Therapeutic Goods Administration (TGA) to reschedule psilocybin and MDMA in 2023 — making Australia the first country to formally approve these substances for clinical use. MMA trains clinicians through its Certificate in Psychedelic-Assisted Therapies (CPAT) program, funds clinical trials, and has supplied medicines and training to 100+ patients under the TGA Authorised Prescriber scheme.

View all Mind Medicine Australia courses

Course FAQ

Who is this course for?

Practitioners interested in ketamine-assisted psychotherapy and psychedelic-assisted psychotherapy practice.

Are there prerequisites?

One listed course is for practitioners who have completed prior KAP training; the other does not list prerequisites in the provided text.

What is the format and time commitment?

Format: Hybrid. Time commitment: 8 weeks.

How much does it cost?

This listing does not have a public price yet. Check the provider website for current tuition, fees, or application-based pricing.

When does the next cohort start?

The listed next cohort date is 2026-12-01.

Is this course currently available?

The current listing status is Active. Use the provider website for the latest enrollment status.

Related Courses

View all courses